The FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.
Pfizer expects migraine sufferers to have access to Zavzpret via a doctor's prescription starting in July 2023.
"Among my migraine patients, one of the most important attributes of an acute treatment option is how quickly it works," said Kathleen Mullin, M.D.
"As a nasal spray with rapid drug absorption, Zavzpret offers an alternative treatment option for people who need pain relief or cannot take oral medications due to nausea or vomiting," one doctor told Fox News Digital.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Weiterlesen »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Weiterlesen »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Weiterlesen »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Weiterlesen »
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Weiterlesen »
FDA approves new nasal spray to treat migraine headaches in adultsThe U.S. Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults, Pfizer said.
Weiterlesen »